SPRR2A and neoplasm: As shown in Figure 5A, in mice injected with CEA‐positive tumor cells, the number of T cells and the ratio of CD8 T cell to CD4 T cell in CEA‐CAR‐T cell in combination with rhIL‐12 treatment group was higher than CEA‐CAR‐T cell treatment group.